Prescrire Int. 2013 May;22(138):138-9.
For various reasons, mainly related to the history of the drug and of drug nomenclature, some INNs lack a common stem. As INN nomenclature has evolved, some stems have been abandoned or their definition has been modified. Some common stems are difficult to interpret or fail to achieve their objective of designating coherent therapeutic groups. This problem tends to arise particularly when: several stems are used for the same therapeutic use; stems used to designate a particular structure or origin are shared by drugs with different properties; or several stems are used to represent drugs with the same properties but different structures.
由于各种原因,主要与药物历史和药物命名法相关,一些国际非专利药品名称(INN)缺乏共同词干。随着INN命名法的演变,一些词干已被废弃或其定义已被修改。一些常见词干难以解释或未能实现其指定连贯治疗组的目标。当出现以下情况时,这个问题往往尤其会出现:几种词干用于相同的治疗用途;用于指定特定结构或来源的词干被具有不同性质的药物共享;或者几种词干用于表示具有相同性质但不同结构的药物。